Versant Venture Capital III, L.P.
Insider CIK 1456586 · OPGN,OPGNW 10% owner · VCYT 10% owner · OCUL 10% owner · FLXN Director, 10% owner · PZRX 10% owner · IMDZ 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FLXN Flexion Therapeutics Inc | P Buy | 2016-06-08 | 2016-06-10 | 710,091 | $14.00 | $9.94M | 3,511,670 | SEC↗ |
| FLXN Flexion Therapeutics Inc | P Buy | 2016-06-08 | 2016-06-10 | 4,194 | $14.00 | $58.7K | 20,739 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 435 | $0.01 | $4 | 8,965 | SEC↗ |
| PZRX PHASERX, INC. | P Buy | 2016-05-23 | 2016-05-24 | 3,523 | $5.00 | $17.6K | 11,408 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 73,615 | $0.01 | $736 | 1,517,531 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 182,914 | $0.01 | $1.8K | 1,334,617 | SEC↗ |
| PZRX PHASERX, INC. | P Buy | 2016-05-23 | 2016-05-24 | 596,477 | $5.00 | $2.98M | 1,931,094 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-24 | 1,080 | $0.01 | $11 | 7,885 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | S Sale | 2015-06-15 | 2015-06-15 | 318,122 | $22.00 | $7.00M | 2,202,377 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | S Sale | 2015-06-15 | 2015-06-15 | 1,878 | $22.00 | $41.3K | 13,007 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | S Sale | 2015-06-10 | 2015-06-11 | 424,494 | $22.00 | $9.34M | 2,520,499 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | S Sale | 2015-06-10 | 2015-06-11 | 2,506 | $22.00 | $55.1K | 14,885 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion deriv | 2015-05-08 | 2015-05-12 | 2,377 | — | $0 | 0 | SEC↗ |
| OPGN,OPGNW OPGEN INC | P Buy deriv | 2015-05-08 | 2015-05-12 | 410,906 | — | $0 | 410,906 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion deriv | 2015-05-08 | 2015-05-12 | 2,957 | — | $0 | 0 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion deriv | 2015-05-08 | 2015-05-12 | 500,565 | — | $0 | 0 | SEC↗ |
| OPGN,OPGNW OPGEN INC | P Buy deriv | 2015-05-08 | 2015-05-12 | 2,426 | — | $0 | 2,426 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion deriv | 2015-05-08 | 2015-05-12 | 402,348 | — | $0 | 0 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion deriv | 2015-05-08 | 2015-05-12 | 6,810 | — | $0 | 0 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion deriv | 2015-05-08 | 2015-05-12 | 1,153,229 | — | $0 | 0 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion | 2015-05-08 | 2015-05-12 | 500,565 | — | $0 | 2,539,214 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion | 2015-05-08 | 2015-05-12 | 2,377 | — | $0 | 12,040 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion | 2015-05-08 | 2015-05-12 | 6,810 | — | $0 | 9,663 | SEC↗ |
| OPGN,OPGNW OPGEN INC | P Buy | 2015-05-08 | 2015-05-12 | 2,426 | $6.00 | $14.6K | 2,853 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion | 2015-05-08 | 2015-05-12 | 2,957 | — | $0 | 14,997 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion | 2015-05-08 | 2015-05-12 | 402,348 | — | $0 | 2,038,649 | SEC↗ |
| OPGN,OPGNW OPGEN INC | C Conversion | 2015-05-08 | 2015-05-12 | 1,153,229 | — | $0 | 1,636,301 | SEC↗ |
| OPGN,OPGNW OPGEN INC | P Buy | 2015-05-08 | 2015-05-12 | 410,906 | $6.00 | $2.47M | 483,072 | SEC↗ |
| FLXN Flexion Therapeutics Inc | X Exercise deriv | 2014-09-10 | 2014-09-12 | 2,250 | — | $0 | 6,750 | SEC↗ |
| FLXN Flexion Therapeutics Inc | X Exercise deriv | 2014-09-10 | 2014-09-12 | 2,250 | — | $0 | 6,750 | SEC↗ |
| FLXN Flexion Therapeutics Inc | X Exercise | 2014-09-10 | 2014-09-12 | 2,250 | $17.61 | $39.6K | 2,250 | SEC↗ |
| FLXN Flexion Therapeutics Inc | X Exercise | 2014-09-10 | 2014-09-12 | 2,250 | $17.61 | $39.6K | 2,250 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | C Conversion deriv | 2014-07-30 | 2014-07-31 | 2,433,816 | — | $0 | 0 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | C Conversion deriv | 2014-07-30 | 2014-07-31 | 198,826 | — | $0 | 0 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | C Conversion deriv | 2014-07-30 | 2014-07-31 | 20,804 | — | $0 | 0 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | C Conversion deriv | 2014-07-30 | 2014-07-31 | 3,523,039 | — | $0 | 0 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | C Conversion deriv | 2014-07-30 | 2014-07-31 | 14,372 | — | $0 | 0 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | C Conversion deriv | 2014-07-30 | 2014-07-31 | 9,563 | — | $0 | 0 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | C Conversion deriv | 2014-07-30 | 2014-07-31 | 1,619,102 | — | $0 | 0 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | C Conversion deriv | 2014-07-30 | 2014-07-31 | 1,174 | — | $0 | 0 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | C Conversion | 2014-07-30 | 2014-07-31 | 2,944,993 | — | $0 | 2,944,993 | SEC↗ |
| OCUL OCULAR THERAPEUTIX, INC | C Conversion | 2014-07-30 | 2014-07-31 | 17,391 | — | $0 | 17,391 | SEC↗ |
| IMDZ Immune Design Corp. | X Exercise deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 305,810 | SEC↗ |
| IMDZ Immune Design Corp. | X Exercise deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 611,620 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 531,840 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 733,941 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 611,620 | — | $0 | 1,877,401 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 733,941 | — | $0 | 733,941 | SEC↗ |
| IMDZ Immune Design Corp. | S Sale | 2014-07-29 | 2014-07-31 | 208,334 | $12.00 | $2.50M | 1,974,877 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 2,183,211 | SEC↗ |
| IMDZ Immune Design Corp. | P Buy | 2014-07-29 | 2014-07-31 | 233,333 | $12.00 | $2.80M | 2,208,210 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 531,840 | — | $0 | 1,265,781 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 18,512 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 3,135,165 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 2,900,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 97,797 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 16,558,351 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 2,277 | — | $0 | 2,899,115 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 385,629 | — | $0 | 2,896,838 | SEC↗ |
| FLXN Flexion Therapeutics Inc | P Buy | 2014-02-18 | 2014-02-20 | 1,806 | $13.00 | $23.5K | 3,206,807 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 12,029 | — | $0 | 2,122,526 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 2,036,697 | — | $0 | 2,110,064 | SEC↗ |
| FLXN Flexion Therapeutics Inc | P Buy | 2014-02-18 | 2014-02-20 | 305,886 | $13.00 | $3.98M | 3,205,001 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 356,703 | — | $0 | 2,511,209 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 18,880 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 42,469 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 3,992,420 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 3,196,673 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 7,190,864 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion deriv | 2013-11-04 | 2013-11-04 | 23,580 | — | $0 | 0 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion | 2013-11-04 | 2013-11-04 | 3,594,989 | — | $0 | 3,594,989 | SEC↗ |
| VCYT VERACYTE, INC. | C Conversion | 2013-11-04 | 2013-11-04 | 21,232 | — | $0 | 21,232 | SEC↗ |